.png){kind=logo}
OUR APPROACH
VISION
Building on our expertise in biotechnology and BIOPURE*, we are leading the transition toward sustainable solutions that enhances human and animal health resilience. We are committed to creating innovative health solutions that honor nature's balance while supporting humanity's pursuit of ever increasing investment profitability.
MISSION
Be a proactive contributor to the WHO «One Health» Program.
STRATEGIC ROADMAP
2026: Multi-Sector Expansion
We will launch dedicated verticals in Animal Health, Agriculture, Human
Health powered by our proprietary solutions-engineered to deliver sustainable, non-antibiotic innovations that enhance health resilience across sectors.
2035: Market Penetration Goal
We aim to capture 1% of the global addressable market, targeting:
Human, Animal Health and Sustainable Agriculture
Our Impact:
-
Enhance profitability
-
Improve sustainability
-
Reduce reliance on antibiotics
*BIOlogical Products Using Responsible Elements
* HBN - Health by Nutrit
GLOBAL CHALLENGES
Antimicrobial Resistance
-
1.25 million deaths attributable to bacteria AMR
-
4.95 million deaths associated with bacterial AMR
-
Deaths from AMR are forecasted to rival the current levels of cancer in coming decades
World Health Organization. (2023). Antimicrobial resistance.
Food Security
-
In 2050 we will need 56% more food to feed nearly 10bn people
-
119m people may still be facing hunger in 2030
-
Nearly 2.4bn people in the world lacked regular access to adequate food in 2022
World Resources Institute. (2018). How to sustainably feed 10 billion people by 2050, in 21 charts.
Greenhouse Gas Emission From Agriculture
-
Emissions from agricultural production currently account for 11% of global greenhouse gas emissions and have risen 14% since 2000
European Environment Agency. (2022). Progress and prospects for decarbonisation.
Supporting A "One Health" Approach
-
Collaborative global approach to understanding
-
Managing rise in health
-
Encouraging a more sustainable ecosystem balance
WHY CHOOSE US?
Science-Driven Innovation
We combine cutting-edge biotechnology with our
proprietary BIOPURE* platform to deliver next-generation, non-antibiotic health solutions designed to address major challenges across human health, animal welfare, and sustainable agriculture.
.png)
Sustainability at the Core
Our solutions are engineered to enhance health resilience while preserving ecological balance supporting both profitability and the planet.
Unmet Market Need
We fill a critical gap with scalable, nature-powered alternatives to traditional antimicrobials, meeting the growing demand for safe, effective, and sustainable health solutions.
Global Vision, Local Impact
With operations across Europe and Asia, we tailor our innovations to regional needs while contributing to global health and sustainability goals.
WHY NOW?
The global demand for nature-powered antimicrobial solutions has never been more urgent.
Existing options are either inefficient or harmful to sustainability goals.
Rising concerns over antimicrobial resistance (AMR) and regulatory pressure are accelerating the shift away from conventional antibiotics.
The market lacks scalable, effective, and eco-conscious alternatives.
lnnova Biotechnology fills this critical gap by delivering BIOPURE* sustainable, high-performance solutions that enhance human and animal health resilience and support sustainable agriculture without compromising environmental integrity or economic viability.
.png)
Escherichia coli
A pathogenic bacterium that is one of the main causes of losses in animal production. Incorrect zoo hygienic conditions, overuse of antibiotics and immunosuppression contribute to the occurrence of infections.
E. coli bacteria cause :
-
Omphalitis and yolk sac inflammation, respiratory colibacillosis, colisepticemia and colibacillosis of the reproductive organs in poultry.
-
Edema disease of weaned piglets (ED) with post-weaning diarrhea.
-
Postpartum agalactia and mastitis in lactating sows.
-
Severe diarrhea and septicemia in calves.
-
Udder inflammation in cows known as coli mastitis.
Clostridium
Clostridium perfringens is responsible for enterotoxemia in sheep and goat
-
Major economic obstacles facing developing countries are attributable to the high fatality rate, decreased productivity, and increased treatment costs.
-
In broilers, it causes clinical or subclinical necrotic enteritis perfringens that leads to decreased digestion and absorption, reduced weight gain and increased feed conversion ratio.
Staphylococcus aureus
Staphylococcus aureus is the main causative agent of mastitis in cattle, sheep, goats and horses
Mastitis in dairy cows causes:
-
A significant economic loss to the dairy industry.
-
Reduction in the milk yield, changes in milk composition, shortens the productive life of affected cows, and is very costly to the dairy farmer.
-
Losses in total milk production from 5.0 to 25.0%, with one extreme of 83.9%
The bacteria may also cause:
-
Dermatitis in sheep and goats.
-
Botryomycosis in pigs and horses, and suppurative infections in cats and dogs.
Journal of Dairy Science. (Vol 53, Issue 9, 1970). Economic Losses Resulting from Mastitis.
Salmonella spp.
In the USA, every year, the CDC* (Atlanta) estimates Salmonella bacteria cause about:
-
1.35 million infections.
-
26,500 hospitalizations.
-
420 deaths.
-
Food is the source for most of these illnesses.
Center for Disease Control and Prevention, NCEZID, DFWED. (2024). Salmonella.
*Center for Disease Control
Pseudomonas spp. and Aeromonas spp.
Fish mortality is a major economic issue in aquaculture
-
The total loss to the aquaculture sector world wide has been estimated to be more than USD 6 billion per annum.
-
One of the leading causes of mortality in farmed fish are infections caused by Pseudomonas spp. and Aeromonas spp. bacteria.
-
These bacteria can cause more than 20% mortality in juvenile populations of species like carp, eel, catfish, salmon, trout.
-
More than 90% of bacteria that developed in saltwater are multi-antibiotic resistant, and 20% are at least resistant to a single antibiotic.
Mycoplasma
Microorganisms cause many clinical changes in the respiratory system.
Mycoplasmas, as pathogens, spread vertically and horizontally.
Mycoplasmosis avium infections are a significant cause of losses in:
-
Chickens with Mycoplasma gallisepticum.
-
Turkeys with Mycoplasma meleagridis.
-
Pigeons with Mycoplasma columborale.
Innovation at our Heart
